South Korean officials refused to suspend the country’s seasonal flu inoculation programme on Oct 22, despite growing calls to do so following the deaths of at least 13 people who were vaccinated in recent days.
Quoteworthy: "It’s not a matter of yes or no — it’s a matter of how much I can get." –— Paul Schulte of equity research firm Schulte Research, referring to appetite among investors for Ant Group’s hotly-anticipated US$35 billion ($47 billion) IPO.
South Korean deaths spark flu vaccine safety fears
![[19/05/26] new top stories](/_next/image?url=https%3A%2F%2Fedgemarkets-transferred.s3-ap-southeast-1.amazonaws.com%2FPEO_KUNHEE_PARK_01_AC_2.jpg%3FTd3bG7fJqxPW3hMZRxhyfGgI25yRRD5v&w=640&q=75)
